Chemical and Toxicological Diagnosis of Acute Poisoning with Clozapine, Olanzapine, Quetiapine and Risperidone
https://doi.org/10.23934/2223-9022-2020-9-2-188-194
Abstract
Relevance The large number of atypical antipsychotic drugs on the market , the breadth of their medical and non-medical use, and their relative affordability make atypical antipsychotics common causes of overdose, suicidal actions or non-medical use of drugs. At the same time, they remain insufficiently studied from the chemical and toxicological point of veiw.
Aim od study: creation of available express method of detection of clozapine, olanzapine, quetiapine and risperidone in the urine of patients with acute poisoning.
Material and methods Thin layer chromatography (TLC), gas chromatography with mass selective detection (GC-MS), and high performance liquid chromatography with mass selective detection (HPLC-MS/MS) were used. The preparation of intact urine samples with addition of standard solutions of clozapine, olanzapine, quetiapine, risperidone and urine samples of patients with symptoms of acute poisoning with given drugs was carried out by methods of liquid-liquid extraction at alkaline pH values for TLC chloroform, a mixture of ethyl acetate-diethyl ether (1:1) for GC-MS and acetonitrile for HPLC-MS/MS.
Results A TLC method has been developed to detect clozapine, olanzapine, quetiapine and risperidone, which allows its the presence to be quickly revealed in the patient’s urine at the preliminary examination stage and also distinguish them from each other in case of the same type of symptoms of poisoning. For confirmatory analysis, it is advisable to use the methods of HPLC-MS/MS and GC-MS. Compared to confirmatory methods, the developed TLC-screening technique is expressive, does not require the use of expensive high-tech equipment and allows clozapine, olanzapine, quetiapine and risperidone to be differentiated from other toxicologically significant psychoactive substances found in general screening.
About the Authors
M. V. BelovaRussian Federation
Doctor of Biological Sciences, Leading Researcher at the Department of Acute Poisoning and Somatopsychiatric disorders; A.P. Arzamastsev Department of Pharmaceutical and Toxicological Chemistry
3 B. Suharevskaya Sq., Moscow 129090
8, b. 2 Trubetskaya St., Moscow 119048
E. A. Klyuyev
Russian Federation
Clinical Laboratory Diagnostics Doctor
3 B. Suharevskaya Sq., Moscow 129090
E. S. Melnikov
Russian Federation
Candidate of Physical Sciences, Assistant of A.P. Arzamastsev Department of Pharmaceutical and Toxicological Chemistry
8, b. 2 Trubetskaya St., Moscow 119048
M. N. Poryadina
Russian Federation
student of A.P. Arzamastsev Department of Pharmaceutical and Toxicological Chemistry
8, b. 2 Trubetskaya St., Moscow 119048
References
1. Isbister GK, Duffull SB. Quetiapine overdose: predicting intubation, duration of ventilation, cardiac monitoring, and the effect of activated charcoal. Int Clin Psychopharmacology. 2009;24(4):174–180. PMID: 19494786 https://doi.org/10.1097/YIC.0b013e32832bb078
2. Springfield AC, Bodiford E. An overdose of risperidone. J Anal Toxicology. 1996; 20(3):202–203. PMID: 8735204. https://doi.org/10.1093/jat/20.3.202
3. Parker DR, Mcinture LM. Case studies of postmortem quetiapine: therapeutic or toxic concentracions? J Anal Toxicology. 2005;29(5):407–412. PMID: 16105271 https://doi.org/10.1093/jat/29.5.407
4. Robertson MD, McMullin MM. Olanzapine concentrations in clinical serum and postmortem blood specimes – when does therapeutic become toxic? J Forensic Sci. 2000;45(2):418–421. PMID: 10782964 https://doi.org/10.1520/JFS14697J
5. Malekshahi T, Tioleco N, Ahmed N, Campbell AN, Haller D. Misuse of atypical antipsychotics in conjunction with alcohol and other drugs of abuse. J Subst Abuse Treat. 2015;48(1):8–12. PMID: 25216812 https:// doi.org/10.1016/j.jsat.2014.07.006
6. De Millas W, Haasen C. Treatment of alcohol hallucinosis with risperidone. Am J Addict. 2007;16(3):249–250. PMID: 17612834 https:// doi.org/10.1080/10550490701375269
7. Slyundin DG, Livanov AS, Anuchin VV, Merkin AG, Bobrinskaya IG, Gutova EV. Specific features of psychopathological manifestations in criminal clozapine intoxications. Neurology, Neuropsychiatry, Psychosomatics. 2010;2(3):57–63. (In Russ.) https://doi.org/10.14412/2074-2711-2010-102.
8. Moffatt AC, Jackson JV, Moss MS, Widdop B. Clarke’s Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids and Post-mortem Material. London: Pharmaceutical Press; 1986.
9. Fisher DS, van Schalkwyk GI, Seedat S, Curran SR, Flanagan RJ. Plasma, oral fluid, and whole-blood distribution of antipsychotics and metabolites in clinical samples. Ther Drug Monit. 2013;35(3):345–351. PMID: 23666566 https://doi.org/10.1097/FTD.0b013e318283eaf2
10. Ostapenko YuN. (ed). Otravleniya psikhotropnymi sredstvami, ne klassifitsirovannymi v drugikh rubrikakh. Federal’nye klinicheskie rekomendatsii. Moscow; 2013. (In Russ.)
11. Kartashov VA, Chernova LV. The detection of quentiapine and olanzapine in the biological objects. Forensic Medical Expertise. 2014;57(5):47–52. (In Russ.)
12. Remezova IP. Development of Methods of Analyses of the Clozapine, Risperidone, Olanzapine, Sertindole, Aripiprazole and Haloperidol in the Model Mixture of Urine. In the World of Scientific Discoveries. 2014;4-1(52):568–583. (In Russ.)
13. Remezova IP, Lazaryan DS, Maksimenko TI, Sanzhieva DY, Rybasova AY. Methods Elaboration on Detection of Some Atypical Neurolytic Agents for Chemical and Toxicological Analysis. Pharmacy & Pharmacology. 2014;2(6(7)):54–58. (In Russ.) https://doi.org/10.19163/2307-9266-2014-2-6(7)-54-58
14. Lazitskaya AM, Chmelevskaya NV, Illarionova EA. Thin-Layer Chromatography in The Analysis of Psychotropic Agents at Combined Poisoning. Acta Biomedica Scientifica. 2017;2(2):74–79. (In Russ.) https://doi.org/10.12737/article_59a614fc20c669.86359679
15. Hendrickson RG, Morocco AP. Quetiapine cross-reactivity among three tricyclic antidepressant immunoassays. J Toxicol Clin Toxicol. 2003;41(2):105–108. PMID: 12733845 https://doi.org/10.1081/CLT-120019122
16. Kartashov VA, Chernova LV. Investigation of quetiapine in the urine of patients with schizophrenia. New Technologies. 2013; (3):160–164. (In Russ.)
17. Baymeeva NV, Bondarenko EV, Potanin SS, Miroshnichenko II. Kolichestvennoe opredelenie soderzhaniya Aripiprazola, Risperidona i ikh aktivnykh metabolitov v plazme krovi cheloveka posredstvom zhidkostnoy tandemnoy khromato-mass-spektrometrii (VEZhKh/MS/ MS). Drug development & registration. 2014;3(8):32–37. (In Russ.)
18. Kirchherr H, Kühn-VeltenWN. Quantitative determination of fortyeight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;843(1):100–113. PMID: 16798119 https://doi.org/10.1016/j.jchromb.2006.05.031
19. Frahnert C, Rao ML, Grasmäder K. Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;794(1):35–47. PMID: 12888196 https://doi.org/10.1016/S1570-0232(03)00393-3
20. Gornostaeva EG, Tupitsina GV. Otravlenie Amitriptilinom. Forensic Medical Expertise. 1974;(2):43–45. (In Russ.)
Review
For citations:
Belova M.V., Klyuyev E.A., Melnikov E.S., Poryadina M.N. Chemical and Toxicological Diagnosis of Acute Poisoning with Clozapine, Olanzapine, Quetiapine and Risperidone. Russian Sklifosovsky Journal "Emergency Medical Care". 2020;9(2):188-194. https://doi.org/10.23934/2223-9022-2020-9-2-188-194